NDC11 00944281401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00944-2814-01 | 00944-2814 |
| 00944-2814-1 | 00944-2814 |
| 0944-2814-01 | 0944-2814 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aralast NP | ALPHA-1-PROTEINASE INHIBITOR (HUMAN) | Takeda Pharmaceuticals America, Inc. | a9a5b46e-04da-41bd-bb5f-c4936b664fef | 2025-11-25 | Warnings, Adverse reactions | 0944-2814-01 0944-2814 00944281401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.